Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-bromophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18BrF3N2O3S
C25H18BrF3N2O3S, monoclinic, P21/n (no. 14), a = 9.9295(11) Å, b = 21.755(2) Å, c = 10.2358(11) Å, β = 95.022(10)°, V = 2202.6(4) Å3, Z = 4, Rgt(F) = 0.0373, wRref(F2) = 0.0795, T = 100(1) K.
Main Authors: | Bai Xian-Yong, Meng Qing-Guo, Hou Gui-Ge, Hou Yun |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-02-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Subjects: | |
Online Access: | https://doi.org/10.1515/ncrs-2019-0715 |
Similar Items
-
Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18ClF3N2O3S
by: Zhou Yan-Qiu, et al.
Published: (2020-02-01) -
Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
by: Al-Sanea Mohammad M., et al.
Published: (2023-04-01) -
Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2
by: Wang An-Qi, et al.
Published: (2020-02-01) -
4-[(Pyridin-3-ylmethylene)amino]phenylhexadecanoate
by: Guan-Yeow Yeap, et al.
Published: (2009-01-01) -
4-[(Pyridin-3-ylmethylene)amino]phenyltetradecanoate
by: Guan-Yeow Yeap, et al.
Published: (2009-01-01)